Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder

Alcoholism: Clinical and Experimental Research

Volumn 29, Issue 3, 2005, Pages 395-401

  Brady, Kathleen T ^a,b   Sonne, Susan ^a   Anton, Raymond F ^a   Randall, Carrie L ^a   Back, Sudie E ^a   Simpson, Kit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alcohol; Alcohol Dependence; Posttraumatic Stress Disorder; Sertraline

Indexed keywords

PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SOCIAL INTERACTION; SYMPTOMATOLOGY;

ADULT; ALCOHOLISM; CLUSTER ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 15944378164     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000156129.98265.57     Document Type: Article

References (51)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC.
2. Anton RF, Moak DH, Latham P (1995) The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 19:92-99.
3. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156:1758-1764.
4. Babor TF, Hofmann M, DelBoca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, Rounsaville B (1992) Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 49:599-608.
5. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM (1995) The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8:75-90.
6. Borg S, Kvande H, Liljeberg P, Mossberg D, Valverius P (1985) 5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions. Alcohol 2:415-418.
7. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM (2000) Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 283:1837-1844.
8. Brady KT, Sonne SC, Roberts JM (1995) Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry 56:502-505.
9. Brown SA, Vik PW, Patterson T, Grant I (1995) Stress, vulnerability and adult alcohol relapse. J Stud Alcohol 56:538-545.
10. Carpenter KM, Brooks AC, Vosburg SK, Nunes EV (2004) The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial. Drug Alcohol Depend 74:123-134.
11. Connor K, Sutherland S, Tupler L, Malik M, Davidson J (1999) Fluoxetine in post-traumatic stress disorder. Br J Psychiatry 175:17-22.
12. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A (1997) Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. Arch Gen Psychiatry 54:700-705.
13. Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum B, Bell J, Maddock R, Hegel MT, Farfel G (2001a) Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry 158:1974-1981.
14. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM (2001b) Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 58:485-492.
15. First MB, Spitzer R, Gibbon M, Williams J (1994) Structured Clinical Interview for Axis I DSM-IV disorders, in Patient Edition (SCID-I/P), version 2.0. American Psychiatric Publishing, Arlington.
16. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT (1999) Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281:1318-1325.
17. Gorelick DA, Paredes A (1992) Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res 16:261-265.
18. Hamilton MA (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
19. Horowitz M, Wilner N, Alvarez W (1979) Impact of Events Scale: A measure of subjective distress. Psychosom Med 41:209-218.
20. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. JAMA 284:963-971.
21. Kabel DI, Petty F (1996) A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment. Alcohol Clin Exp Res 20:780-784.
22. Kadden R, Carroll K, Donovan D, Cooney M, Monti P, Abrams D, Litt, M, Hester R (1995) Cognitive-Behavioral Coping Skills Therapy Manual (National Institute on Alcohol Abuse and Alcoholism Project MATCH Monograph Series, Volume 3). National Institutes of Health, Bethesda. (NIH publication No. 94-3724)
23. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52:1048-1060.
24. Kosten T, Frank J, Dan E (1991) Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 179: 366-370.
25. Kosten TA, Miserendino MJ, Kehoe P (2000) Enhanced acquisition of cocaine self-administration in adult rats with neonatal isolation stress experience. Brain Res 875:44-50.
26. Kranzler HR, Burleson JA, Brown J, Babor TF (1996) Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin Exp Res 20:1534-1541.
27. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N (1995) Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397.
28. Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS (1996) Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry 153:83-92.
29. Le Marquand D, Pihl RO, Benkelfat C (1994) Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 36: 326-337.
30. Liu X, Weiss F (2002) Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22:7856-7861.
31. Marshall RD, Beebe KL, Oldham M, Zaninelli R (2001) Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry 158:1982-1988.
32. Martenyl F, Brow EB, Zhang H, Koke SC, Prakash A (2002) Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. Br J Psychiatry 181:315-320.
33. McLellan AT, Parikh G, Bragg A, Cacciola J, Fureman B, Incmikoski R (1990) Addiction Severity Index: Administration Manual. 5th ed. Pennsylvania Veterans' Administration Center for Studies of Addiction, Philadelphia.
34. Moak DH, Anton RF, Latham PK, Voronin KE, Waid LR, Durazo-Arvizu R (2003) Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol 23:553-562.
35. Monti PM, Abrams DB, Kadden RM, Cooney NL (1989) Treating Alcohol Dependence: A Coping Skills Training Guide. Guilford Press, New York.
36. Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D, Sellers EM (1990) Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 47:490-498.
37. Naranjo CA, Sellers EM (1989) Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers. Recent Dev Alcohol 7:255-266.
38. Naranjo CA, Sellers EM, Roach CA, Woodley DV, Sanchez-Craig M, Sykora K (1984) Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers. Clin Pharmacol Ther 35:374-381.
39. Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K (1987) The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 41:266-274.
40. Nunes EV, Quitkin FM, Donovan SJ, Deliyannides D, Ocepek-Welikson K, Koenig T, Brady R, McGrath PJ, Woody G (1998) Imipramine treatment of opiate-dependent patients with depressive disorders. Arch Gen Psychiatry 55:153-160.
41. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49:881-887.
42. Petrakis I, Carroll KM, Nich C, Gordon L, Kosten T, Rounsaville B (1998) Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug Alcohol Depend 50:221-226.
43. Pettinati HM (2001) The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes. J Clin Psychiatry 62:26-31.
44. Pettinati HM, Dundon W, Lipkin C (2004) Gender differences in response to sertraline pharmacotherapy in type A alcohol dependence. Am J Addict 13:236-247.
45. Pettinati HM, Volpicelli JR, Kranzler HR, Luck G, Rukstalis MR, Cnaan A (2000) Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res 24: 1041-1049.
46. Project MATCH Research Group (1997) Matching alcoholism treatments to client heterogeneity. Project MATCH posttreatment drinking outcomes. J Stud Alcohol 58:7-29.
47. Schmitz JM, Averill P, Stotts AL, Moeller FG, Rhoades HM, Grabowski J (2001) Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug Alcohol Depend 63:207-214.
48. Sobell LC, Sobell MB (1992) Timeline Follow-Back: a technique for assessing self-reported ethanol consumption, in Measuring Alcohol Consumption: Psychological and Biological Methods (Allen J, Litten RZ eds), pp 41-72. Humana Press, Totowa.
49. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD (2001) Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 62:860-868.
50. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G (1994) Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 55:517-522.
51. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880.